Status:
COMPLETED
Youth Metacognitive Therapy Feasibility Trial
Lead Sponsor:
University of Manchester
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Greater Manchester Mental Health NHS Foundation Trust
Conditions:
Child Mental Disorder
Anxiety Disorders
Eligibility:
All Genders
11-16 years
Phase:
NA
Brief Summary
One in eight children and young people (CYP) suffer mental health problems needing support or treatment and 5% have more than one such problem. The effects can be major, affecting CYP emotionally and ...
Eligibility Criteria
Inclusion
- Seeking treatment for emotional disorder symptoms (i.e. generalized anxiety disorder, panic disorder, agoraphobia, post-traumatic stress disorder, obsessive compulsive disorder, social anxiety and/or depression).
- Native fluency in English language
- Medication permitted but must be stabilised for 6 weeks.
Exclusion
- Presence of significant risk or safeguarding concerns
- Head injury/organic impairment
- Formal diagnosis or under assessment for Autism Spectrum Disorder or Attention Deficit-Hyperactivity Disorder
- Eating Disorder
Key Trial Info
Start Date :
May 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2024
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT05260060
Start Date
May 23 2022
End Date
April 4 2024
Last Update
June 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom, M13 9WL